{"entity":{"id":"nct07371663","kind":"trial","name":"An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors","aka":[],"tldr":"A phase 1/2 trial of TCC1727 tablet 90mg in non-small-cell lung cancer, gastric & gastro-oesophageal junction cancer, endometrial cancer and melanoma, run by Beijing Tide Pharmaceutical Co., Ltd, now recruiting.","summary":"An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT07371663 by Beijing Tide Pharmaceutical Co., Ltd, with 266 participants planned, started 2025-12-03 and due to reach its primary completion in 2028-09-30. Interventions recorded: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg and benmelstobart Injection.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07371663","url":"https://clinicaltrials.gov/study/NCT07371663"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["nsclc","gastric","endometrial","melanoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07371663","phase":"1/2","setting":"An Open-Label, Multicenter Phase Ib/II Clinical Trial of TCC1727 in Combination With Benmelstobart/Olaparib/Topotecan for Advanced Solid Tumors","sponsor":"Beijing Tide Pharmaceutical Co., Ltd","enrolled":266,"outcomes":[]},"route":"/trials/nct07371663/","neighbours":{"cancer":[{"id":"endometrial","kind":"cancer","name":"Endometrial cancer","route":"/cancers/endometrial/"},{"id":"gastric","kind":"cancer","name":"Gastric & gastro-oesophageal junction cancer","route":"/cancers/gastric/"},{"id":"melanoma","kind":"cancer","name":"Melanoma","route":"/cancers/melanoma/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"company":[{"id":"beijing-tide-pharmaceutical","kind":"company","name":"Beijing Tide Pharmaceutical","route":"/companies/beijing-tide-pharmaceutical/"}]}}